CSIRO reeling after wheat virus outbreak
02 May, 2003 by Melissa TrudingerIt's a nightmare scenario -- scientists forced to destroy months, even years of their labour to combat an outbreak of a virus never seen in Australia. And it has just happened at CSIRO Plant Industry, where thousands of plants have recently been destroyed to combat the wheat streak mosaic virus (WSMV), a cereal plant pathogen that has never before been identified in Australia.
GM pioneer points to thaw in public opposition
02 May, 2003 by Graeme O'NeillThere are signs that, even in the UK and Europe, consumer and political attitudes towards GM crops and foods are thawing, according to the scientist who has led the global campaign for GM agriculture, Prof Channapatna S Prakash.
Australian consumers don't mind GM: survey
02 May, 2003 by Graeme O'NeillA new survey suggests the great 'Frankenfood' scare could be over in Australia before it has even begun.
Back GM or see our agriculture markets wilt, conference told
02 May, 2003 by Melissa TrudingerAustralia runs the risk of being left behind if it does not adopt the production of GM crops, according to two recent reports presented at this week's Ag-Biotech Forum in Melbourne.
Ambri tightens its belt, looks for cash
01 May, 2003 by Pete YoungMedical diagnostics company Ambri is striving to tap fresh funding sources while engaging in further staff and cost cutbacks to stretch dwindling cash reserves.
Regulatory framework questioned in Pan fiasco
29 April, 2003 by Jeremy TorrRecent revelations about Pan Pharmaceuticals and Curacel International have thrown the efficacy of Australia's regulatory system into question, with potentially thousands of product lines facing recall and criminal charges being filed.
CSIRO Animal Health asked to join SARS fight
24 April, 2003 by Melissa TrudingerUnited Nations health authorities have asked CSIRO's Australian Animal Health Laboratory (AAHL) to join in the global effort to combat the SARS virus.
Biota set to research neo-epidemics
24 April, 2003 by Jeremy TorrWith SARS ravaging Asia and avian flu decimating Dutch poultry farms, antiviral company Biota is to ramp up activities within the both the treatment and diagnostic fields.
GM virus puts mice off sex
23 April, 2003 by Jeremy TorrAustralia's first GM mammal virus is poised to slash millions of dollars off grain spoilage figures, if medium-scale mouse-limitation trials go according to plan
Radiation technique shows good results in weight reduction trials
22 April, 2003 by Jeremy TorrInnovative RF radiation techniques have resulted in positive weight reduction results, according to a recent University of Adelaide study.
Prana sets sights on Alzheimer's diagnostic
17 April, 2003 by Jeremy TorrPossible links between the pathology of the eye and the brain have been identified by Prana consultants working on Alzheimer's patients.
New targets ID'd in hunt for clotting reduction drugs
16 April, 2003 by Melissa TrudingerMonash University scientists have identified potential new targets for the development of drugs to reduce blood clotting in patients at risk of heart attack or stroke.
EvoGenix, Genesis team to target new anti-inflammatories
15 April, 2003 by Melissa TrudingerA trans-Tasman collaboration between New Zealand's Genesis R&D and Sydney-based EvoGenix will target a novel target for anti-inflammatory therapeutics.
Genesis R&D to spin off plant division
15 April, 2003 by Melissa TrudingerNew Zealand's largest biotechnology company, Genesis Research and Development, is spinning out its plant division into a separate, fully owned company to maximise the value of its assets, according to CEO Dr Jim Watson.
Benitec licenses to US supplier Promega
11 April, 2003 by Pete YoungGene silencing company Benitec has taken a giant stride forward on the world stage by sealing a global licensing agreement for its technology with leading life sciences industry supplier Promega Corp.
